Mandate

Mars Petcare acquires AniCura

June 13, 2018 M&A

Vinge advises Fidelio Capital in connection with entering into an agreement with Mars Petcare regarding Mars Petcare's acquisition of AniCura.

AniCura was founded in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm through the first merger of companion animal hospitals in the Nordic region. Since then the company grown to become one of Europe’s leading providers of high-quality veterinary care for companion animals and today AniCura has more than 4,000 veterinary professionals who provides modern, high-quality veterinary care for pets at 200 European locations across seven European countries. In 2014, Nordic Capital joined the company as a majority owner, with Fidelio Capital remaining as a significant shareholder. The acquisition is subject to customary regulatory approvals.

Vinge’s team consisted of, among others, Jonas Bergström and Joacim Rydergård.
 

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026